Sponsors
Show: March 10, 2013:
- A bitter pill to swallow
- Poor sleep can lead to poor health
- Aspirin resistance or 'pseudo-resistance?'
- Doc chat: Diagnosing alcohol abuse
- When 'never events' become real events
- Are we making headway against neurofibromatosis?
- Grace Notes #21: Kindness
- View all topics for the week
Sound Medicine is brought to you by:
Are we making headway against neurofibromatosis?
Host: Barbara Lewis
Interview: Kent Robertson, M.D., Ph.D., associate director of pediatric stem cell transplantation, assistant professor, Department of Pediatrics, Indiana University School of Medicine.
Kent Robertson, M.D., conducted a ground breaking new study that could change the outlook for neurofibromatosis sufferers. Neurofibromatosis is a disease caused by a single genetic mutation that causes life-threatening tumors in children. The tumors are slow growing, unresponsive to chemotherapy and radiation, and almost always grow close to vital organs. In a study conducted by Dr. Robertson, 23 patients received the drug Gleevec. After six months of treatment five patients had one or more tumors reduce in size. Although the study conducted was small, Dr. Roberson believes this treatment will eventually bring relief to those suffering from neurofibromatosis.
Additional Resources:
- Learn more about neurofibromatosis here
Find us on:
Listen to us free at:
